Open access
839
Views
100
CrossRef citations to date
0
Altmetric
Review
The Risks of miRNA Therapeutics: In a Drug Target Perspective
Song Zhang1 Jiangxi Institute of Respiratory Disease, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, People’s Republic of China;2 College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, People’s Republic of China
, Zhujun Cheng3 Department of Burn, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, People’s Republic of China
, Yanan Wang1 Jiangxi Institute of Respiratory Disease, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, People’s Republic of China
& Tianyu Han1 Jiangxi Institute of Respiratory Disease, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, People’s Republic of ChinaCorrespondence[email protected]
Pages 721-733
|
Published online: 22 Feb 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.